about
Pharmacists' perceptions of pay for performance versus fee-for-service remuneration for the management of hypertension through pharmacist prescribing.Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, CanadaPharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people's lives in the context of health care trends, evidence and policiesIs travel health a new destination for pharmacy practice and business? An examination of revenue opportunities from pre-travel consultationsWill I lose my license for that? A closer look at Canadian disciplinary hearings and what it means for pharmacists' practice to full scopeGetting it in the right spot: Shoulder injury related to vaccine administration (SIRVA) and other injection site eventsMedication management issues identified during home medication reviews for ambulatory community pharmacy patientsUptake of Travel Health Services by Community Pharmacies and Patients Following Pharmacist Immunization Scope Expansion in Ontario, CanadaTime for harmonization: Pharmacists as immunizers across Canadian jurisdictionsMaking it happen: Strategies to incorporate vaccinations into community pharmacy practiceDevelopment and Testing of a Clinical Practice Framework for Pharmacists to Assess Patients' Travel-Related Risks: The 5W Approach to Travel Risk IdentificationTravelers' diarrhea: Clinical practice guidelines for pharmacistsThe International Pharmacists-as-Immunizers Partnership (IPIP)-Advancing Research on Pharmacist-Administered Immunizations WorldwideTravel Medicine Curricula across Canadian Pharmacy Programs and Alignment with Scope of Practice
P50
Q38769178-BB692BFC-A677-4655-8E4E-ED25BA89DB7FQ61811367-A4AFCB3B-050F-414B-BC77-6FEE2454D338Q61813323-EAD70058-9276-4434-8DDA-158AE26FADCBQ64321210-749C8F02-7420-4D72-A8D7-A2B0E4F63E95Q64323993-E2D53208-952F-48A9-994A-B509718FBA26Q64323999-3D44CB42-8CD3-4C70-B44E-10CFA8CD33B9Q90170032-F31C365F-636E-4F80-A3AC-EDE9F21EDC11Q90240296-1140EE8D-89AD-4886-873F-4B280EA96340Q91427733-17079750-1E14-4A3B-8D60-5949E709D36CQ91427764-31E1B0BA-20DF-4296-A479-3E5082DD4FECQ91513188-31253ABA-874E-44A0-A98B-012DEF3383D1Q92005313-4496B63F-3A6B-432C-BAB4-CD2356D8587DQ92543200-F589501D-C71A-46F6-A77A-A2661B655FB4Q96438105-55F5C368-2DB5-402C-A48B-445B3E15AF0D
P50
description
researcher
@en
name
Sherilyn Houle
@en
type
label
Sherilyn Houle
@en
prefLabel
Sherilyn Houle
@en
P31
P496
0000-0001-5084-4357